Mimedx (MDXG) Revenue Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33% |
| Dec 31, 2025 | 11.49% |
| Sep 30, 2025 | 12.08% |
| Jun 30, 2025 | 12.95% |
| Mar 31, 2025 | 7.40% |
| Dec 31, 2024 | 3.99% |
| Sep 30, 2024 | -1.11% |
| Jun 30, 2024 | 5.28% |
| Mar 31, 2024 | 4.94% |
| Dec 31, 2023 | -1.28% |
| Sep 30, 2023 | -1.24% |
| Jun 30, 2023 | -3.16% |
| Mar 31, 2023 | -3.16% |
| Dec 31, 2022 | -3.28% |
| Sep 30, 2022 | -4.23% |
| Jun 30, 2022 | -3.64% |
| Mar 31, 2022 | -3.06% |
| Dec 31, 2021 | -6.17% |
| Sep 30, 2021 | -0.42% |
| Jun 30, 2021 | 3.52% |
| Mar 31, 2021 | 2.36% |
| Dec 31, 2020 | 5.75% |
| Sep 30, 2020 | 5.58% |
| Jun 30, 2020 | 3.27% |
| Mar 31, 2020 | 8.65% |
| Dec 31, 2019 | 14.06% |
| Sep 30, 2019 | 21.53% |
| Jun 30, 2019 | 21.40% |
| Mar 31, 2019 | 27.75% |
| Dec 31, 2018 | 38.77% |
| Sep 30, 2018 | 40.09% |
| Jun 30, 2018 | 47.83% |
| Mar 31, 2018 | 48.75% |
| Dec 31, 2017 | 52.91% |
| Sep 30, 2017 | 60.23% |
| Jun 30, 2017 | 75.14% |
| Mar 31, 2017 | 79.36% |
| Dec 31, 2016 | 92.62% |
| Sep 30, 2016 | 97.35% |
| Jun 30, 2016 | 97.07% |
| Mar 31, 2016 | 119.66% |